Company intelligence / Profile preview

Equinox Biotech

Guangzhou, Guangdong, China

Ownership: Private
Employees: ~750
Development stage: Other

Overview

Rapid diagnostic kits are commercially available globally with regulatory approvals including CE marking, ISO13485 certification, FDA510(k), and Health Canada approval for select products. No clinical trial data is relevant as these are diagnostics.

Therapeutic areas: Infectious DiseasesPsychiatryOncologyWomen's Health
Modalities: Diagnostic test kits (e.g., immunoassay-based rapid tests)Membrane for biological diagnostic kits (polymer biomedical functional materials)
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Equinox Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Equinox Biotech.

Explore the full profile